New treatment methods for patients with hypertrophic obstructive cardiomyopathy

Current Opinion in Cardiology

Volumn 15, Issue 3, 2000, Pages 172-177

  Lakkis, Nasser ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ANGINA PECTORIS; BALLOON CATHETER; DYSPNEA; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MYOTOMY; PRIORITY JOURNAL; REVIEW;

ANGINA PECTORIS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CORONARY ANGIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; HEMODYNAMIC PROCESSES; HUMANS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 0034117493     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200005000-00009     Document Type: Review

References (20)

1. 1 Maron BJ, Gardin JM, Flack JM Jurosaki TT, Bild TE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995, 92:785-789.
2. 2 Spirito P, Seidman C, McKenna W, Maron B: The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
3. 3 Frank MJ, Abdullah AM, Canedo MI, Saylors RE: Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol 1978, 42:993-1003.
4. 4 Lakkis NM, Killip D, Spencer WH III: Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol 1997, 20:417-418.
5. 5 Robbins RC, Stinson EB, Daily PO: Long-term results of myotomy and myectomy for hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg 1996, 111:586-594.
6. 6 Mohr R, Schaff H, Danielson GK: The outcome of surgical treatment for hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 1998, 97:666-674. Landmark paper in that it reports the longest follow-up data of surgical intervention in HOCM.
7. 7 Duck VHJ, Hutschenreiter W, Pankau H, Trenckmann H: Vorhofsynchrone ventrikelstimulation mit verkuvzker a.v. verzogerungszeit alstherapieprenzip der hypertrophischen obstruktiven kardiomyopathie. Z Gesamte Inn Med 1984, 39:437-439.
8. 8 Jeanrenaud X, Goy J-J, Kappenberger L: Effects of dual chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992, 339:1318-1323.
9. 9 Fananapazir L, Cannon RO III, Tripodi D, Panza J: Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992, 85:2149-2161.
10. 10 Fananapazir L, Epstein ND, Panza A, Curiel R, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994, 90:2731-2742.
11. 11 Nishimura RA, Trusty JM, Hayes DL: Dual-chamber pacing for hypertrophic obstructive cardiomyopathy: a randomized, double-blind, crossover study. J Am Coll Cardiol 1997, 29:435-441.
12. 12 Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999, 99:2927-2933. Multicentered study that objectively evaluated the efficacy of pacing in patients with refractory symptoms due to HOCM.
13. 13 Sigwart U, Grbie M, Essinger A, River JL: L'effet aigu d'une occlusion coronarienne par ballonet de la dilatation transluminale [abstract]. Schweiz Med Wochenschr 1982, 45:1631.
14. 14 Geitzen F, Lenner C, Gerenkamp T, Kuhn H: Relief of obstruction in hypertrophic obstructive cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery [abstract]. Eur Heart J 1994, 15:125.
15. 15 Sigwart U: Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 1995, 346:211-214.
16. 16 Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He Z-X, Verani MS, et al.: Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998, 98:1750-1755. First US report to evaluate the role of echocardiography in alcohol ablation for HOCM, including the role of myocardial contrast.
17. 17 Nagueh SF, Lakkis NM, He Z-X, Middleton KJ, Killip D, Zoghbi WA, et al.: Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998, 32:225-229.
18. 18 Segewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S: Catheter treatment of hypertrophic obstructive cardiomyopathy: acute and 3-months follow-up. J Am Coll Cardiol 1997, 31:252-258.
19. 19 Knight C, Kurbaan AS, Seggewiss H, Sigwart U: Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997, 95:2075-2081.
20. 20 Petrakian A, Spencer WH III, Lakkis NM, Payne J: Electrophysiological testing in patients undergoing ethanol septal reduction for hypertrophic cardiomyopathy [abstract]. PACE 1999, 22:749.